Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulated mRNA Transport02:22

Regulated mRNA Transport

6.8K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.8K
RNA Editing02:23

RNA Editing

9.7K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
Neural Regulation01:37

Neural Regulation

43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Subviral Agents01:29

Subviral Agents

437
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
437
RNA Splicing01:32

RNA Splicing

60.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular RNA in iron-induced hepatic injury: Beyond TLR3 toward an integrated inflammatory axis.

Toxicology reports·2025
Same author

Extracellular RNA drives TNF-α/TNF-receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1.

Pharmacological research·2025
Same author

Editor's Note: Cell Surface Tetraspanin Tspan8 Contributes to Molecular Pathways of Exosome-Induced Endothelial Cell Activation.

Cancer research·2025
Same author

Non-cadaveric spine surgery simulator training in neurosurgical residency.

North American Spine Society journal·2024
Same author

Nucleic acid liquid biopsies in cardiovascular disease: Cell-free RNA liquid biopsies in cardiovascular disease.

Atherosclerosis·2024
Same author

The Complement System Is Essential for Arteriogenesis by Enhancing Sterile Inflammation as a Relevant Step in Collateral Artery Growth.

Cells·2024

Related Experiment Video

Updated: Jan 4, 2026

In vivo Interrogation of Central Nervous System Translatome by Polyribosome Fractionation
09:13

In vivo Interrogation of Central Nervous System Translatome by Polyribosome Fractionation

Published on: April 30, 2014

12.6K

Extracellular RNA in Central Nervous System Pathologies.

Katharina Tielking1, Silvia Fischer2, Klaus T Preissner2

  • 1Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Frontiers in Molecular Neuroscience
|November 5, 2019
PubMed
Summary

Extracellular RNA (exRNA) plays a key role in cell communication and disease. This review explores exRNA

Keywords:
CNS pathologiesbrain metastasiscerebral occlusive diseasesextracellular RNAextracellular vesiclesglioblastoma multiformemultiple sclerosisneuroinflammation

More Related Videos

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
08:53

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells

Published on: May 16, 2017

9.1K
Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
07:14

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

6.4K

Related Experiment Videos

Last Updated: Jan 4, 2026

In vivo Interrogation of Central Nervous System Translatome by Polyribosome Fractionation
09:13

In vivo Interrogation of Central Nervous System Translatome by Polyribosome Fractionation

Published on: April 30, 2014

12.6K
Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
08:53

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells

Published on: May 16, 2017

9.1K
Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
07:14

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

6.4K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Background:

  • Extracellular RNA (exRNA) encompasses diverse RNA species released from cells.
  • exRNA can be free, protein-bound, or vesicle-associated (microvesicles, exosomes, apoptotic bodies).
  • Ribosomal exRNA (rexRNA) acts as a proinflammatory and prothrombotic alarmin, contributing to innate immunity and cardiovascular pathologies.

Purpose of the Study:

  • To review the entities of exRNA and their roles in central nervous system (CNS) pathologies.
  • To discuss the potential of exRNAs as diagnostic markers for CNS diseases.
  • To outline treatment strategies targeting exRNA inhibition or interference.

Main Methods:

  • Literature review of studies on exRNA composition, function, and roles in disease.
  • Analysis of exRNA involvement in CNS tumors, vascular pathologies, and neuroinflammatory diseases.
  • Exploration of exRNA as a diagnostic biomarker and therapeutic target.

Main Results:

  • exRNA, particularly rexRNA, promotes inflammation and contributes to cardiovascular diseases.
  • Various exRNA species are implicated in CNS pathologies, though precise roles require further elucidation.
  • exRNAs show potential as diagnostic markers and therapeutic targets for CNS disorders.

Conclusions:

  • exRNA is crucial in cell communication and various pathologies, including CNS diseases.
  • Further research is needed to fully understand exRNA's role in CNS disorders.
  • Targeting exRNA presents promising avenues for diagnostics and therapeutics in CNS diseases.